Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors

Figure 1

Computed tomography chest scans of three patients, showing response to docetaxel and irinotecan (DI) combination. No lung lesion was visible (complete response) after five cycles of DI in unique patient number (UPN) 1. UPNs 6 and 9 showed decreases in tumor (arrow) measurements of 40% after five cycles and 50% after three cycles, respectively, indicating partial responses by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.

Back to article page